Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Other Accumulated Expenses: 2020-2022

Historic Other Accumulated Expenses for Candel Therapeutics (CADL) over the last 3 years, with Dec 2022 value amounting to $48,000.

  • Candel Therapeutics' Other Accumulated Expenses rose 54.84% to $48,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $48,000, marking a year-over-year increase of 54.84%. This contributed to the annual value of $48,000 for FY2022, which is 85.63% down from last year.
  • As of FY2022, Candel Therapeutics' Other Accumulated Expenses stood at $48,000, which was down 85.63% from $334,000 recorded in FY2021.
  • Candel Therapeutics' 5-year Other Accumulated Expenses high stood at $334,000 for FY2021, and its period low was $48,000 during FY2022.
  • Its 3-year average for Other Accumulated Expenses is $189,667, with a median of $187,000 in 2020.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first surged by 78.61% in 2021, then tumbled by 85.63% in 2022.
  • Over the past 3 years, Candel Therapeutics' Other Accumulated Expenses (Yearly) stood at $187,000 in 2020, then spiked by 78.61% to $334,000 in 2021, then slumped by 85.63% to $48,000 in 2022.